University of Michigan Rogel Cancer Center: Breast Neoplasms trials

The registry lists 39 Breast Neoplasms studies with University of Michigan Rogel Cancer Center as lead sponsor. 4 are open to participants now and 12 have results posted.

Early Phase 1 1Phase 1 8Phase 2 10Phase 4 1No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsRecruitingNCT07291414Not applicable
• Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingNCT07158021Phase 2
• CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast CancerRecruitingNCT06915168Not applicable
• Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerRecruitingNCT05183126Phase 4
• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• Lighting Intervention for Cancer-related FatigueCompletedNCT04827446Not applicableResults posted
• Altering Lipids for Tolerance of Aromatase Inhibitor TherapyCompletedNCT04268134Phase 2Results posted
• The ConnectedCancerCare Pilot Study (CCC)CompletedNCT03618017Not applicableResults posted
• Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast CancerCompletedNCT01896050Results posted
• Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer PatientsCompletedNCT01814397Results posted
• Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated PainCompletedNCT01028352Not applicableResults posted
• Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast CancerTerminatedNCT00726180Phase 1/2Results posted
• Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerCompletedNCT00645333Phase 1/2Results posted
• Partial Breast Irradiation Using Accelerated Intensity Modulated RadiotherapyTerminatedNCT00581529Phase 2Results posted
• A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast CancerCompletedNCT00581256Phase 1/2Results posted
• Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian FailureTerminatedNCT00555477Phase 2Results posted
• Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast CancerCompletedNCT06228768Not applicable
• Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast CancerActive, not recruitingNCT05996107Phase 1
• Cardiac Rehabilitation to Improve Breast Cancer OutcomesTerminatedNCT05867667Not applicable
• Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision AidCompletedNCT05140252Not applicable
• An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer SurvivorsCompletedNCT05030792Not applicable
• Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerCompletedNCT04703920Phase 1
• Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to TrastuzumabCompletedNCT03135171Phase 1
• Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast CancerTerminatedNCT02712437Not applicable
• Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant ChemotherapyCompletedNCT02679586Early Phase 1
• The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)Active, not recruitingNCT02400190Not applicable
• Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer PatientsCompletedNCT02338115
• Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast CancerTerminatedNCT01975597
• Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast CancerCompletedNCT01477489Phase 1
• Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast CancerCompletedNCT00967824Phase 1/2
• UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerCompletedNCT00900094
• A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerCompletedNCT00399321
• Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast CancerCompletedNCT00161265
• Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and CapecitabineCompletedNCT00156312Not applicable
• Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast CancerCompletedNCT00156273
• Feasibility Study of Evaluating Breast Cancer Patients With Ductal LavageTerminatedNCT00156260
• Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast CancerCompletedNCT00148070Phase 2
• UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast CancerCompletedNCT00146042Phase 2
• Companion Pharmacogenetic Study to UMCC 9900/9901TerminatedNCT00146029